Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (135)

2023

  1. CLINICAL VIEW ON SUBSTANCE-INDUCED PSYCHOTIC SYMPTOMS IN A MEDICALLY SUPERVISED INJECTING ROOM: A DECADE OF EXPERIENCE

    Actas espanolas de psiquiatria, Vol. 51, Núm. 4, pp. 188-191

  2. Clinical features and factors related to lifetime suicidal ideation and suicide attempts in patients who have had substance-induced psychosis across their lifetime

    Psychiatry Research, Vol. 323

  3. Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survival

    Clinical and experimental rheumatology, Vol. 41, Núm. 8, pp. 1695-1703

2022

  1. A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

    Neuropsychiatric Disease and Treatment, Vol. 18, pp. 965-976

  2. Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)

    Scientific Reports

  3. Confirmatory factor analysis of 20-item toronto alexithymia scale in spanish patients with substance use disorder

    Actas espanolas de psiquiatria, Vol. 50, Núm. 5, pp. 208-215

  4. Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry

    Seminars in Arthritis and Rheumatism, Vol. 55

  5. Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)

    Autoimmunity Reviews, Vol. 21, Núm. 10

2021

  1. Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life

    Frontiers in Psychiatry, Vol. 12

  2. Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))

    Autoimmunity Reviews

  3. Is alexithymia related to retention and relapses in patients with substance use disorders?: A one year follow-up study

    Addictive Behaviors, Vol. 113

  4. Psychiatric Comorbidity and Addiction Severity Differences in Patients With ADHD Seeking Treatment for Cannabis or Cocaine Use Disorders

    Journal of Attention Disorders, Vol. 25, Núm. 7, pp. 978-988

  5. Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol withdrawal: A systematic review

    European Review for Medical and Pharmacological Sciences, Vol. 25, Núm. 13, pp. 4554-4562

  6. Psychosis induced by abuse of ayahuasca: a case report

    Revista Colombiana de Psiquiatria, Vol. 50, Núm. 1, pp. 43-46

  7. The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i)

    Rheumatology (Oxford, England), Vol. 60, Núm. 2, pp. 872-880

  8. Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit

    Addictive Behaviors, Vol. 117

  9. Validation of the Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales in French, Spanish, and German Languages, among a Sample of Opioid Users

    European Addiction Research, Vol. 27, Núm. 5, pp. 326-331

2020

  1. Benefits of EEG-Neurofeedback on the Modulation of Impulsivity in a Sample of Cocaine and Heroin Long-Term Abstinent Inmates: A Pilot Study

    International Journal of Offender Therapy and Comparative Criminology, Vol. 64, Núm. 12, pp. 1275-1298

  2. Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review

    Reproductive Health, Vol. 17, Núm. 1

  3. Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease

    Quality of Life Research, Vol. 29, Núm. 3, pp. 607-617